Evidence map›Paper›PMID 28595490›Full record

ArticleThe American journal of psychiatry2017

The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-Relative, Co-Spouse, and Within-Individual Analysis.

Kenneth S Kendler, Henrik Ohlsson, Dace S Svikis, Kristina Sundquist, Jan Sundquist

Open access · bronzeAbstract readTwin Study
In one paragraph

Article in The American journal of psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Marijuana use, fetal growth, and uterine artery Dopplers.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2022
    Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kenneth S KendlerFrom the Virginia Institute for Psychiatric and Behavioral Genetics, the Department of Psychiatry, the Department of Human and Molecular Genetics, the Department of Psychology, and the Institute for Women's Health, Virginia Commonwealth University, Richmond; and the Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Henrik OhlssonFrom the Virginia Institute for Psychiatric and Behavioral Genetics, the Department of Psychiatry, the Department of Human and Molecular Genetics, the Department of Psychology, and the Institute for Women's Health, Virginia Commonwealth University, Richmond; and the Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Dace S SvikisFrom the Virginia Institute for Psychiatric and Behavioral Genetics, the Department of Psychiatry, the Department of Human and Molecular Genetics, the Department of Psychology, and the Institute for Women's Health, Virginia Commonwealth University, Richmond; and the Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Kristina SundquistFrom the Virginia Institute for Psychiatric and Behavioral Genetics, the Department of Psychiatry, the Department of Human and Molecular Genetics, the Department of Psychology, and the Institute for Women's Health, Virginia Commonwealth University, Richmond; and the Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Jan SundquistFrom the Virginia Institute for Psychiatric and Behavioral Genetics, the Department of Psychiatry, the Department of Human and Molecular Genetics, the Department of Psychology, and the Institute for Women's Health, Virginia Commonwealth University, Richmond; and the Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Virginia Commonwealth University · US

Funding

Clinical Trials Network: Mid-Atlantic Integrated Care Research CollaborativeUG1DA013034 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BIGELOW, GEORGE, SCHWARTZ, ROBERT P · 2015 to 2019
$11.0M
Genetic, Social, and Developmental Epidemiology of Drug Use DisordersR01DA030005 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KENNETH SEEDMAN KENDLER, JAN O SUNDQUIST · 2010 to 2026
$7.6M
NIDA NIH HHS R01 DA030005NIDA NIH HHS UG1 DA013034
6 · The paper itself

Abstract

objectiveThe authors sought to determine whether pregnancy is an intrinsic motivator for cessation of drug abuse.

methodThe authors conducted prospective cohort, co-relative, co-spouse, and within-person analyses of registration for drug abuse during pregnancy among Swedish women born between 1980 and 1990 who gave birth between ages 20 and 35 (N=149,512). Drug abuse was assessed from medical, criminal, and pharmacy registries.

resultsIn the population, rates of drug abuse were lower during pregnancy (unadjusted odds ratio=0.67, 95% CI=0.60, 0.74). Compared with population results, the negative association between pregnancy and drug abuse was moderately stronger in cousins (odds ratio=0.49, 95% CI=0.39, 0.62) and substantially stronger in siblings (odds ratio=0.35, 95% CI=0.24, 0.51) discordant for pregnancy. The estimated odds ratio for drug abuse in pregnancy-discordant monozygotic twins was even stronger, at 0.17 (95% CI=0.10, 0.31). Within individuals, the odds ratio for drug abuse while pregnant compared with an equivalent prepregnancy interval was similar to that seen in pregnancy-discordant monozygotic twins, at 0.22 (95% CI=0.19, 0.26). Compared with cohabiting fathers, mothers had a greater reduction in risk for drug abuse during pregnancy (odds ratio=0.40, 95% CI=0.34, 0.47). Pregnancy was more protective in women with low parental education and without a cohabiting, actively drug-abusing father. Compared with prepregnancy baseline, within-individual analyses indicate that risk for drug abuse is also substantially reduced in the postpartum period, for example, the odds ratio for postpartum days 0-242 was 0.13 (95% CI=0.11, 0.16).

conclusionsRisk for drug abuse in women is substantially reduced during pregnancy. Multiple analyses suggest that this association is largely causal, suggesting that pregnancy is indeed a strong intrinsic motivator for drug abuse cessation. Similar strong protective effects may be present in the immediate postpartum period. Our results have implications for our etiologic models of drug abuse and especially for contingency management programs seeking to reduce drug abuse risk.

Indexed as

FathersMothersPostpartum PeriodRegistriesTwins, MonozygoticAdultCohort StudiesFemaleHumansMaleOdds RatioPregnancyProspective StudiesProtective FactorsRisk FactorsSpousesEpidemiologyPsychoactive Substance Use Disorder

Identifiers

PMID28595490
PMCPMC5624829
OpenAlexW2622001025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.